Elle Strategy
HomeInsights

Insights & Case Studies

What International Expansion Actually Looks Like

Case studies from CPG, consumer health, and higher education expansions — and the strategic thinking behind them. Details have been anonymised to protect client confidentiality.

Case Studies

Three Expansions. Three Sectors. One Framework.

CPGSoutheast Asia
Market PriorityRoute to MarketBrand Architecture & Cultural Localisation

From Single-Market Brand to Regional Platform: A CPG Expansion Across Five ASEAN Markets

A mid-market ambient food brand with strong domestic share in the UK sought to establish a regional presence across Southeast Asia. The challenge was not demand — category growth was robust — but channel fragmentation, distributor capability gaps, and a brand architecture built entirely around Western health credentials that carried little resonance in target markets.

The Challenge

The brand's core USP — "clean label, no additives" — was a powerful driver in the UK but largely irrelevant in markets where processed food is aspirational and international provenance is the primary purchase driver. Simultaneously, the distributor landscape across Indonesia, Vietnam, Thailand, Malaysia, and the Philippines was highly fragmented, with no single partner offering credible coverage across modern trade and the emerging e-commerce channel.

Our Approach

  1. 1Applied Market Priority framework to rank the five target markets by modern trade penetration, category growth rate, and regulatory complexity — producing a sequenced entry plan with Indonesia and Thailand as Phase 1 markets.
  2. 2Conducted distributor capability assessments across 14 candidate partners in Phase 1 markets, evaluating cold chain infrastructure, key account relationships, and field sales capacity.
  3. 3Ran a structured USP localisation exercise: repositioned the brand from "clean label" to "internationally trusted quality" — a claim with significantly higher purchase intent scores in both markets.
  4. 4Developed market-specific pack architecture: retained the master brand but introduced locally adapted flavour naming, on-pack imagery, and a Bahasa Indonesia / Thai language hierarchy that placed provenance cues prominently.

Outcome

Achieved weighted distribution targets in modern trade within 9 months of Phase 1 launch. Brand awareness tracking showed 34% unaided recall among target shoppers in Indonesia after 12 months — ahead of plan. Phase 2 markets (Vietnam, Malaysia, Philippines) entered on schedule 18 months after initial launch.

Key Insight

The single highest-leverage intervention was the USP localisation. The product did not change. The channel did not change. Repositioning the brand's lead claim around international provenance rather than ingredient transparency increased trial conversion by an estimated 22% in consumer research — before a single unit was shipped.

Consumer Health / OTCLatin America
Market PriorityCapital AllocationOperating ModelBrand Architecture & Cultural Localisation

Regulatory-First Market Entry for an OTC Analgesic Brand Across Four Latin American Markets

A European consumer health company with a well-established OTC analgesic portfolio sought to enter Brazil, Mexico, Colombia, and Chile. The brand had strong clinical evidence and a clear efficacy positioning — but no experience navigating the regulatory complexity of Latin American OTC classification, and a brand architecture that had never been tested outside of European pharmacy channels.

The Challenge

OTC classification for the active ingredient varied across the four target markets — ranging from general sale in Chile to prescription-only in Brazil for certain dosage forms. This created a fragmented regulatory roadmap with materially different time-to-revenue profiles, capital requirements, and route-to-market options in each market. The brand's European positioning — built on clinical trial data and pharmacist recommendation — also required significant adaptation for markets where self-medication culture, health literacy, and the role of the pharmacist differ substantially.

Our Approach

  1. 1Applied Market Priority framework with regulatory classification as a primary filter — producing a sequenced entry plan that prioritised Chile and Colombia (faster OTC pathways) ahead of Mexico and Brazil.
  2. 2Built a market-specific capital allocation model that incorporated regulatory registration timelines, local QP requirements, and the working capital implications of distributor-led versus direct pharmacy models.
  3. 3Designed a lean operating model for Phase 1: regional regulatory affairs hub in Colombia, local commercial representation in Chile, and a shared services model for finance and supply chain.
  4. 4Conducted a cultural health beliefs audit across all four markets — identifying that "fast relief" was a universal driver but that the credibility signals differed: clinical data resonated in Chile and Colombia, while natural ingredient provenance and family heritage cues were stronger purchase drivers in Mexico.
  5. 5Developed a brand architecture that retained the master brand but introduced locally adapted sub-brand names, pack colour systems, and on-pack claim hierarchies calibrated to each market's regulatory and cultural context.

Outcome

Phase 1 markets (Chile, Colombia) achieved regulatory approval within projected timelines. The adapted brand architecture delivered significantly higher pharmacist recommendation rates than the unadapted European creative in consumer research. Mexico registration completed 4 months ahead of schedule following a regulatory pathway identified during the Market Priority phase.

Key Insight

Treating regulatory classification as a market prioritisation variable — not just a compliance task — fundamentally changed the sequencing and capital efficiency of the expansion. Entering Chile first, rather than Brazil (the largest market), allowed the brand to build regional commercial infrastructure and generate early revenue while the Brazil registration was in progress.

Higher EducationSouth & Southeast Asia
Market PriorityRoute to MarketBrand Architecture & Cultural LocalisationCommercial Milestones

Transnational Education Expansion: Building a Credible Brand Architecture Across Three Asian Markets

A UK university with strong research rankings sought to expand its transnational education (TNE) footprint across India, Malaysia, and Singapore. The institution had an established brand in the UK but limited recognition in target markets — and faced the structural challenge common to TNE expansion: how to leverage institutional reputation without overextending the master brand into markets where it carries little equity.

The Challenge

The university's brand architecture had been built entirely around UK domestic positioning — research excellence, graduate employability in the UK market, and campus experience. None of these were primary purchase drivers for students in India, Malaysia, or Singapore, where the decision to pursue a transnational qualification is driven by cost-relative-to-outcome, employer recognition of the qualification in the local job market, and the credibility of the local delivery partner.

Our Approach

  1. 1Applied Market Priority framework using student mobility data, bilateral recognition agreements, and local accreditation requirements as primary filters — ranking Singapore as a premium positioning market, Malaysia as a partnership-led volume market, and India as a digital-first recruitment market.
  2. 2Evaluated 22 potential local delivery partners across the three markets against a structured capability matrix: academic governance standards, student support infrastructure, employer relationships, and financial stability.
  3. 3Conducted a brand architecture review: recommended an endorsed brand model for Malaysia and Singapore (local partner brand endorsed by the UK institution) and a direct digital brand for India, where the UK institution's name carried sufficient aspirational value to drive direct enrollment.
  4. 4Ran a USP localisation exercise for each market: in Singapore, led with graduate salary outcomes and employer partnerships; in Malaysia, led with qualification recognition and pathway to UK postgraduate study; in India, led with international credential and digital flexibility.
  5. 5Developed a commercial milestone framework with enrollment pipeline KPIs, student satisfaction (NPS) targets, and employer recognition metrics — with quarterly review cadence and defined escalation triggers for underperforming partnerships.

Outcome

Year 1 enrollment targets met in Malaysia and Singapore. India digital enrollment exceeded target by 31% in the first intake cycle. The endorsed brand model in Malaysia produced significantly higher conversion rates than the direct institutional brand tested in a parallel pilot — validating the brand architecture recommendation.

Key Insight

The most consequential finding was that the institution's strongest asset — its UK research ranking — was largely irrelevant to the purchase decision in all three markets. Students were buying a credential, a career outcome, and a pathway. Rebuilding the brand narrative around those drivers, rather than institutional prestige, was the single most impactful change in the go-to-market approach.

Thought Leadership

The Strategic Questions That Define International Expansion

Brand Strategy8 min read

Why Your USP Probably Doesn't Travel

The proof points that built your brand at home are rarely the ones that will build it abroad. A framework for identifying which claims translate, which need reframing, and which need replacing entirely.

Request the full paper
Market Entry6 min read

The Distributor Selection Mistake Most Mid-Market Firms Make

Selecting a distributor on the basis of market coverage alone is one of the most common — and costly — errors in international expansion. What to evaluate instead, and how to structure agreements that protect your brand.

Request the full paper
Consumer Health7 min read

Regulatory Classification as a Strategic Variable

OTC classification is not just a compliance question — it is a market prioritisation variable that determines your time-to-revenue, capital requirements, and route-to-market options. How to build it into your expansion sequencing.

Request the full paper
Higher Education9 min read

The Brand Architecture Decision Every TNE Expansion Gets Wrong

Master brand, endorsed brand, or local brand? The structural choice that governs every subsequent localisation decision — and why most institutions default to the wrong answer for the wrong reasons.

Request the full paper
CPG7 min read

Cultural Penetration vs. Market Entry: A Distinction That Matters

Getting a listing is not the same as building a brand. The difference between CPG brands that achieve sustainable share and those that plateau after launch is almost always a cultural localisation question, not a distribution question.

Request the full paper
Capital Strategy5 min read

The Minimum Viable Investment for International Market Entry

How to structure a phased investment model that proves the market without overcommitting capital — and the decision gates that should govern each subsequent phase of spend.

Request the full paper

Work With Us

Ready to apply this thinking to your expansion?

The patterns in these case studies are not unique to the firms involved. If you are a mid-market CPG, consumer health, or higher education organisation evaluating international expansion, we would welcome a conversation about how the Prism framework applies to your specific situation.

Request a ConsultationExplore the Model